Research
Energy balance
At 12 months, patients who persisted in treatment experienced an average weight loss of 9.6%, with 65% surpassing a 5% weight loss.
Long-term adherence to treatment can lead to significant weight loss.
StrongSupportsmedium confidence
At 12 months, patients who persisted in treatment (21%) experienced an average weight loss of 9.6%, with 65% surpassing a 5% weight loss.
Why this rating
Based on the multicenter study design with a large cohort.
Source
Efficacy of phentermine/topiramate extended release in weight management and metabolic profiles: A multicentre study in South Korea
Kyoung Min Kim et al. · Diabetes Obesity and Metabolism · 2025
cohort · n=1839Cited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →